Protective effect of quinacrine on striatal dopamine levels in 6-OHDA and MPTP models of Parkinsonism in rodents

Brain Research Bulletin

Volumn 54, Issue 1, 2001, Pages 77-82

  Tariq, Mohammad ^a   Khan, Haseeb Ahmad ^a   Moutaery, Khalaf Al ^a   Deeb, Saleh Al ^a  

^a The General Directorate of Armed Forces Health Services   (Saudi Arabia)

Author keywords

6 OHDA; Dopamine; Glutathione; MPTP; Oxidative stress; Parkinsonism; Phospholipase

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; GLUTATHIONE; HOMOVANILLIC ACID; MEPACRINE; OXIDOPAMINE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOSE RESPONSE; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSONISM; PRIORITY JOURNAL; RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BRAIN CHEMISTRY; DOPAMINE; ENZYME INHIBITORS; GLUTATHIONE; HOMOVANILLIC ACID; MALE; MICE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; OXIDOPAMINE; PARKINSONIAN DISORDERS; PHOSPHOLIPASES; QUINACRINE; RATS; RATS, WISTAR; SYMPATHOLYTICS;

EID: 0035134340     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(00)00427-5     Document Type: Article

References (79)

1. Effects of beta-carotene, flavonoid quercitin and quinacrine on cell proliferation and lipid peroxidation breakdown products in BHK-21 cells
2. Protective effects of pergolide on dopamine levels in the 6-hydroxydopamine lesioned mouse brain
3. Mediators of injury in neurotrauma; Intracellular signal transduction and gene expression
4. Progress in understanding the pathophysiology of cerebral ischemia; The almitrine-raubasine approach
5. Effect of 6-hydroxydopamine on brain norepinephrine and dopamine; Evidence for selective degeneration of catecholamine neurons
6. NMDA antagonists partially protect against MPTP induced neurotoxicity in mice
7. 2 inhibits dopamine-mediated behavior in rats; Possible implications for schizophrenia
8. Hypokinesia produced by anterolateral hypothalemic 6-hydroxydopamine lesions and its reversal by some antiparkinson drugs
9. Long-term behavioral and biochemical effects of 6-hydroxydopamine injections in rat caudate-putamen
10. Role of dopamine autooxidation, hydroxyl radical generation and calcium overload in underlying mechanism involved in MPTP-induced parkinsonism
11. 2 after transient global forebrain ischemia in the rat
12. Ro 16-6491; A new reversible and highly selective MAO-B inhibitor protects mice from the dopaminergic neurotoxicity of MPTP
13. 2-induced neurotoxicity and epileptic seizures after intracerebral administration; An unexplained heterogeneity as emphasized with paradoxin and crotoxin
14. 2 activation influences the processing and secretion of the amyloid precursor protein
15. 2 in neurodegeneration
16. Effects of nicotine on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced depression of striatal dopamine content and spontaneous locomotor activity in C57 black mice
17. 2 activity in schizophrenia
18. Effects of nimodipine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced depletions in the biogenic amine levels in mice
19. Molecular mechanisms for neurodegeneration; Synergism between reactive oxygen species, calcium and excitotoxic amino acids
20. Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse
21. 2 activation caused by tumor necrosis factor
22. Basic fibroblast growth factor stimulation of glial cells protects dopamine neurons from 6-hydroxydopamine toxicity-involvement of the glutathione system
23. Biochemical pathophysiology of Parkinson's disease
24. 2 are resistant to MPTP neurotoxicity
25. 2 in dopamine secretion by rat neuronal PC cells
26. Free radical-generated neurotoxicity of 6-hydroxydopamine
27. Pretreatment with nimodipine prevents MPTP-induced neurotoxicity at the nigral, but not at the striatal level in mice
28. Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice
29. Lysophosphatidylcholine and the inflammatory action of neutrophils
30. AIDS-related dementia and calcium homeostasis
31. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease
32. Reversal of parkinsonian symptoms in primates by antagonism of excitatory amino acid transmission; Potential mechanisms of action
33. Rotational behavior and neurochemical changes in unilateral N-methyl-norsalsolinol and 6-hydroxydopamine lesioned rats
34. Sulfhydryl drugs reduce neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse
35. Arachidonic acid and lysophosphatidylcholine modulate excitatory transmitter amino acid release from the rat cerebral cortex
36. A possible role of phospholipases in the release of neurotransmitter amino acids from the ischemic rat cerebral cortex
37. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine
38. Central nervous system bioaminergic responses to mechanic trauma
39. Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain
40. Dose dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine
41. 2 mechanisms in the development of stimulant sensitization
42. 2
43. Regulation of arachidonic acid release by enzyme(s) of rat brain cortex
44. Thioctic acid does not restore glutathione levels or protect against the potentiation of 6-hydroxydopamine toxicity induced by glutathione depletion in rat brain
45. Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
46. Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonism
47. 2+ channel
48. 2) immunoreactivity is elevated in Alzheimer's disease brain
49. 3H]nitrendipine binding to rat cardiac membranes
50. Quinacrine inhibits oxygen radicals release from human alveolar macrophages
51. + neurotoxicity by N-methyl-D-aspartate antagonists
52. 2
53. Diethyldithiocarbamate causes nigral cell loss and dopamine depletion with nontoxic does of MPTP
54. +, apoptosis induced by 6-OHDA in PC12 cells is independent of mitochondrial inhibition
55. + toxicity in nigral dopaminergic neurones